
Opinion|Videos|August 14, 2024
74- year-old man with LRMDS and Transfusion Dependent Anemia
Author(s)Abdulraheem Yacoub, MD
Advertisement
Episodes in this series

Clinical Presentation: 74-year-old man diagnosed 1 years ago with LR-MDS with moderate anemia (Hb 11.2 g/dL) Non-del(5q)
• No family history of cancer or significant genotoxic agent exposure
• Serum EPO - 250m U/L, Ring sideroblast (RS) positive • IPSS-R: Low
• Received 2 units of blood every 2 months for 4 months; at that point they started therapy with ESAs.
• At 12 weeks, Hb remained essentially the same (11.4 g/dL) and transfusion needs decreased.
• At 20 weeks, his Hb is now 10.8 g/dL and he now is requiring 2-3 units of blood every month.
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Improving Survival, Quality of Life, and Cost-Effectiveness for Allo-HCT
2
FDA Panel Votes 10-3 In Favor of RP1 Plus Nivolumab for Advanced Melanoma
3
FDA Approves Lutetium Lu 177 Vipivotide Tetraxetan Plus ARPI in mAPMN/S Prostate Cancer
4
July 2026 in Oncology: A Look Back at FDA Approvals and Decisions
5



































